Solna

• A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Letrozole Compared to Letrozole Alone in Postmenopausal Wom … Ended
  2024-512848-30-00 4 2024-11-12 HORMONE RECEPTOR-POSITIVE, HER2-NEGATIVE BREAST CANCER
• A Phase 2a, Randomised, Double-blind, Parallel and Placebo-controlled Trial Investigating Safety and Efficacy of LIB-01 in Treatment of Erec … Ended
  2024-515065-34-00 4 2024-11-07 Erectile dysfunction (ED)
• Investigator initiated clinical trial of dantrolene as a treatment for Darier disease Ended
  2024-519201-36-00 4 2024-11-07 Darier disease
• A Phase 1b, Double-blind, Placebo-controlled, Randomised Trial Investigating the Effect of AZD3427 on Renal Perfusion in HFrEF Patients With … Ended
  2024-513143-82-00 3 2024-10-15 Heart failure with reduced ejection fraction
• A Phase I/IIa Study of ODX (OsteoDex) in Multiple Myeloma Ended
  2024-516969-36-00 9 2024-09-16 Multiple Myeloma
• A study to test whether BI 1819479 improves lung function in people with idiopathic pulmonary fibrosis (IPF). Ended
  2023-508395-11-00 4 2024-09-10 idiopathic pulmonary fibrosis
• A study to learn how safe starting vericiguat at a dose of 5 milligrams is in participants with chronic heart failure with reduced ejection … Ended
  2023-507682-25-00 4 2024-05-13 Chronic heart failure with reduced ejection fraction
• BIOMarkers in Endometrial Cancer - A phase III open label randomized trial to determine the efficacy of biomarker staging as compared to con … Ended
  2023-505991-31-00 5 2024-04-30 ENDOMETRIAL CANCER
• A trial to learn how much [11C]savolitinib enters the brains of healthy participants Ended
  2023-508334-34-00 3 2024-03-27 Healthy Volunteers
• Safety and Immunogenicity of V116 in Children and Adolescents With Increased Risk for Pneumococcal Disease Ended
  2023-506236-32-00 5 2024-03-25 Pneumococcal disease
• Brain effects of hormonal contraceptives. Ended
  2023-507842-10-00 6 2024-03-18 Contraception
• A study to investigate efficacy and safety of OG-6219 twice a day in 3 dose levels compared with Placebo in participants aged 18 to 49 with … Ended
  2022-501310-57-00 4 2024-02-05 Endometriosis related pain
• Phase 1/2a Open-Label, Dose-Escalation, Multicenter, First in-Human, Consecutive-Cohort, Clinical Trial of BI 1910, a Monoclonal Antibody to … Ended
  2022-503066-74-00 7 2023-12-04 Advanced solid tumors
• A Multicenter, Adaptive, Randomized, Controlled Trial Platform to Evaluate Safety and Efficacy of Strategies and Treatments for Hospitalized … Ended
  2023-504487-41-00 5 2023-11-28 COVID-19
• REIMAGINE 2: A research study to see how well CagriSema compared to semaglutide, cagrilintide and placebo lowers blood sugar and body weight … Ended
  2022-502678-18-00 5 2023-11-07 Type 2 diabetes
• A study to learn how gadoquatrane moves into, through, and out of the body and how safe it is in children aged 0 to less than 18 years, who … Ended
  2022-501883-17-00 5 2023-10-16 Contrast enhancement in magnetic resonance imaging in children
• A study to find a suitable dose of BI 1821736 and test whether it helps people with advanced cancer Ended
  2022-502125-17-00 1 2023-10-16 Advanced solid tumors
• A study to compare how well gadoquatrane works and its safety with an already available contrast agent for MRI in people with known or suspe … Ended
  2022-501884-41-00 5 2023-09-29 Contrast enhancement in magnetic resonance imaging for assessment of c
• Phase 2/3 Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer Ended
  2022-502196-31-00 10 2023-08-21 Advanced or Recurrent Endometrial Cancer
• A study to evaluate Intravitreal JNJ-81201887(AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary … Ended
  2022-500746-16-00 4 2023-08-11 Geographic Atrophy
• Clinical trial of MK-7648A in adults and children with skin cancer Ended
  2022-501417-31-01 5 2023-08-01 melanoma
• Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD (ACTIVATE study) Ended
  2022-501783-18-00 4 2023-07-21 Parkinson’s Disease
• Study of M5049 in DM and PM Participants (NEPTUNIA) Ended
  2022-501351-82-00 4 2023-05-23 Dermatomyositis, Polymyositis
• A positron emission tomography (PET) study to assess where the radiotracer [11C]AZ14132516 goes in the body following administration to heal … Ended
  2022-502843-36-00 1 2023-04-27 Crohn's disease

Showing 313–336 of 382 trials